Over the last few decades, biomedical research has unraveled a plethora of pathophysiological steps putatively important for human disease development. But it was only in the last few years that a broader translation from basic research efforts to clinical medicine has indeed occurred. This was largely made possible by the close cooperation of basic researchers and clinical investigators, aiming at the development of truly effective therapeutics. Inflammatory skin diseases serve as an example of this successful bench-to-bedside approach. Currently, more and more therapies are approved as a result of this scientific approach, and many more are on their way, with psoriasis being the best example of translational medicine.
Nevertheless, a stand-alone meeting in which inflammatory skin diseases and the translational revolution that we are currently experiencing take center stage is currently lacking. We have taken upon the task of organizing such an important meeting in order to continue this path of therapeutic revolution and extend to other inflammatory skin diseases. The meeting is named “Inflammatory Skin Disease Summit: The Translational Revolution”. It will be held under the auspices of the Austrian National Academy of Sciences and take place on November 19-21, 2014 in Vienna, Austria.